IFNA2 and hepatitis C virus infection: To assess the in vivo relevance of EV-mediated antiviral immunity, we isolated EVs from serum of Caucasian patients with acute hepatitis C before and during antiviral therapy with pegylated (PEG)-IFN-α and ribavirin (no serum samples of Japanese patients with acute hepatitis C were available), Figure 7.